Osteoporosis
📧 Sign up to get email alerts when something new happens for Osteoporosis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2007-07-17FDA Approved: EVISTA — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for EVISTA (raloxifene hydrochloride) from Eli Lilly and Company.
-
FDA approval · 2007-05-19FDA Approved: TERIPARATIDE — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for teriparatide submitted by Prasco Laboratories.
-
CLINICAL_TRIALS trial_result · 2007-05-09Clinical Trial Update: The Effect of a Short Educational Program on Young Women's Knowledge and Beliefs About Osteoporosis [Phase 1]
A Phase 1 clinical trial assessed whether a short educational program could improve young women's knowledge and beliefs about osteoporosis. …
-
FDA approval · 2007-04-26FDA Approved: FOSAMAX PLUS D — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for FOSAMAX PLUS D (alendronate sodium and cholecalciferol) submitted by Organon LLC. This appro…
-
CLINICAL_TRIALS trial_result · 2007-04-25Clinical Trial Update: FORCE (Falls, Fracture, and Osteoporosis Risk Control Evaluation) Study [NA]
The FORCE study on Falls, Fracture, and Osteoporosis Risk Control Evaluation has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2007-04-20Clinical Trial Update: Study of Male Osteoporosis and Aging
This update describes a clinical study on osteoporosis in men and aging, sponsored by Odense University Hospital, with the current study sta…
-
FDA approval · 2007-04-16FDA Approved: ACTONEL — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for Actonel (risendronate sodium) by Allergan, Inc., under NDA 020835.
-
CLINICAL_TRIALS research · 2007-04-12Clinical Trial Update: The Study of the Early Administration of Alendronate on Prevention of Bone Loss After Hip Fracture. [Phase 3]
A Phase 3 clinical trial is evaluating whether early administration of Alendronate after hip fracture can prevent bone loss in people with o…
-
CLINICAL_TRIALS trial_result · 2007-03-20Clinical Trial Update: The Genetic and Life Style Determinants of Bone Mass of Young Greek Males
A completed University of Athens study examining genetic and lifestyle determinants of bone mass in young Greek males and its relation to os…
-
CLINICAL_TRIALS trial_result · 2007-02-27Clinical Trial Update: Women's Use of Alternative Medicine: A Multiethnic Study
This update reports the completion of a multiethnic clinical trial on women's use of alternative medicine, sponsored by the NCCIH. It addres…
-
CLINICAL_TRIALS trial_result · 2007-02-27Clinical Trial Update: Hormone Replacement in Young Women With Premature Ovarian Failure [Phase 2]
Phase 2 clinical trial update on hormone replacement therapy for young women with premature ovarian failure; the study status is completed w…
-
CLINICAL_TRIALS trial_result · 2007-01-26Clinical Trial Update: Teriparatide Use in Hip Replaced Subjects [Phase 3]
Phase 3 clinical trial update evaluating the use of teriparatide in hip-replaced patients with osteoporosis has completed.
-
CLINICAL_TRIALS trial_result · 2007-01-26Clinical Trial Update: Bone Effects of Teriparatide Following Alendronate [Phase 3]
A Phase 3 trial evaluating the bone effects of teriparatide after alendronate therapy for osteoporosis has completed.
-
CLINICAL_TRIALS research · 2007-01-26Clinical Trial Update: Compliance and Acceptance of Teriparatide Injection in Severely Osteoporotic Patients [Phase 3]
Phase 3 clinical trial update on compliance and acceptance of teriparatide injection in severely osteoporotic patients.
-
CLINICAL_TRIALS trial_result · 2007-01-04Clinical Trial Update: Low-Dose Hormone Replacement Therapy and Alendronate for Osteoporosis [Phase 3]
Phase 3 trial evaluating low-dose hormone replacement therapy with alendronate for osteoporosis and osteopenia was terminated.
-
CLINICAL_TRIALS trial_result · 2006-12-29Clinical Trial Update: Osteoporosis Prevention in Preadolescent Girls [Phase 2]
A Phase 2 clinical trial sponsored by NIAMS evaluating osteoporosis prevention in preadolescent girls has completed.
-
FDA approval · 2006-12-28FDA Approved: FOSAMAX PLUS D — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Fosamax Plus D (alendronate sodium and cholecalciferol) from Organon LLC.
-
CLINICAL_TRIALS research · 2006-11-27Clinical Trial Update: Preliminary Study for Identification of Calcium-Binding Proteins in the Serum in Various Metabolic Bone Disorders
This is a preliminary clinical trial study aimed at identifying calcium-binding proteins in serum across metabolic bone disorders. Condition…
-
CLINICAL_TRIALS trial_result · 2006-11-17Clinical Trial Update: Upper GI Handling of Branded vs. Generic Alendronate [Phase 3]
A Phase 3 trial evaluating upper GI handling of branded Fosamax versus generic alendronate in osteoporosis has completed.
-
CLINICAL_TRIALS trial_result · 2006-09-15Clinical Trial Update: HRT Versus Etidronate for Osteoporosis and Fractures in Asthmatics Receiving Glucocorticoids. [Phase 4]
A Phase 4 trial comparing hormone replacement therapy with etidronate for osteoporosis and fractures in asthmatics receiving glucocorticoids…
-
CLINICAL_TRIALS trial_result · 2006-09-15Clinical Trial Update: Randomized Trial of Osteoporosis Intervention Strategies in Hip Fracture Patients [NA]
Completed randomized trial evaluating osteoporosis intervention strategies in patients with hip fracture.
-
CLINICAL_TRIALS trial_result · 2006-09-04Clinical Trial Update: Lead Exposure, Genetics, and Osteoporosis Epidemiology
A NIEHS-sponsored clinical trial on lead exposure, genetics, and osteoporosis epidemiology has completed.
-
CLINICAL_TRIALS trial_result · 2006-08-18Clinical Trial Update: Macrobiotic Diet and Flax Seed: Effects on Estrogens, Phytoestrogens, & Fibrinolytic Factors [Phase 2]
Phase 2 clinical trial evaluating a macrobiotic diet and flax seed on estrogens, phytoestrogens, and fibrinolytic factors. The study status …
-
CLINICAL_TRIALS trial_result · 2006-08-18Clinical Trial Update: Dietary Phytoestrogens and Bone Metabolism [Phase 2]
Phase 2 clinical trial evaluating the effect of dietary phytoestrogens on bone metabolism in osteoporosis; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2006-08-17Clinical Trial Update: Therapeutic Touch for Wrist Fractures in Postmenopausal Women [Phase 2]
This update summarizes a Phase 2 clinical trial evaluating Therapeutic Touch for wrist fractures in postmenopausal women with osteoporosis. …